Dr Reddy’s Knocked Back On Canadian Semaglutide

Receives Notice of Non-Compliance From Pharmaceutical Drugs Directorate

 
• By Anju Ghangurde
  
Maple leaves
Dr Reddy's received negative feedback from the Canadian regulator for semaglutide (Shutterstock)

More from Generics

More from Products